MARKET

CORT

CORT

Corcept Therapeutics Inc
NASDAQ
114.08
+3.31
+2.98%
Opening 14:25 08/10 EDT
OPEN
110.84
PREV CLOSE
110.77
HIGH
114.49
LOW
110.05
VOLUME
560.41K
TURNOVER
--
52 WEEK HIGH
122.21
52 WEEK LOW
28.66
MARKET CAP
12.33B
P/E (TTM)
267.72
1D
5D
1M
3M
1Y
5Y
1D
High-flyer healthcare stocks: Ten names with strong momentum, weak valuations
Seeking Alpha · 5h ago
Weekly Report: what happened at CORT last week (0803-0807)?
Weekly Report · 9h ago
Top Corcept Executive Cashes In on Significant Stock Sale
TipRanks · 4d ago
Corcept Therapeutics Stock Shines at New All-Time Highs Despite Its Valuation
Barchart · 6d ago
AstraZeneca tops pharma growth rankings while Bristol Myers trails amid merger talks
Seeking Alpha · 08/03 12:11
Weekly Report: what happened at CORT last week (0727-0731)?
Weekly Report · 08/03 09:19
OTLK, HBAN, CORT, CAPR, GOSS Trending With Analysts
TipRanks · 08/01 09:01
Buy/Sell: Wall Street’s top 10 stock calls this week
TipRanks · 07/31 19:06
More
About CORT
Corcept Therapeutics Incorporated is a commercial-stage company. The Company is engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol. It is also conducting advanced clinical trials in patients with solid tumors, Amyotrophic Lateral Sclerosis (ALS) and liver disease. It operates through the discovery, development and commercialization of the pharmaceutical products segment. It sells Korlym and a generic version of Korlym in the United States using sales representatives to call on physicians caring for patients with hypercortisolism (Cushing’s syndrome). The Company's portfolio of selective cortisol modulators consists of four series totaling approximately 1,000 compounds. It sells and distributes Lifyorli in the United States. It is developing its proprietary, selective cortisol modulator, relacorilant, as a treatment for patients with hypercortisolism.

Webull offers Corcept Therapeutics Inc stock information, including NASDAQ: CORT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CORT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CORT stock methods without spending real money on the virtual paper trading platform.